Atorable EZ 40 Tablet contains Atorvastatin 40mg + Ezetimibe 10mg, a high-strength dual-action combination used for effective management of high cholesterol and mixed dyslipidemia. It helps in significantly lowering LDL cholesterol and triglycerides, while improving HDL levels, thereby reducing cardiovascular risk.
Atorvastatin works by blocking cholesterol synthesis in the liver, while Ezetimibe inhibits intestinal cholesterol absorption. This dual mechanism provides enhanced lipid-lowering efficacy compared to monotherapy, making it suitable for patients with difficult-to-control cholesterol levels.
This tablet is commonly prescribed for patients requiring more intensive lipid-lowering therapy, particularly those at high risk for cardiovascular events. Its once-daily oral dosage ensures convenient administration and improved compliance for long-term therapy.
For PCD pharma franchise partners, Atorable EZ 40 Tablet is a high-demand cardiac care product, available at the best price for PCD pharma franchise. Its clinical reliability, strong prescriber trust, and steady market demand make it a valuable addition to any cardiology or lipid-lowering product portfolio.